基本信息
浏览量:0
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
个人简介
Dr. Leong’s mandate is to bring lab-grown ideas to the clinic, with a particular focus on the genitourinary system (kidney, bladder, prostate, testes, urethra, penis). The constant goal is to take concepts developed in the lab and translate them into clinical practice. The group emphasizes multidisciplinary training and collaboration to help trainees become confident and highly skilled scientists.
Dr. Leong is focused on developing “liquid biopsies” that rely on the enumeration of circulating cancer cell fragments, also known as extracellular vesicles, in the blood. Whether they are used to improve early detection for early-stage migration in pancreatic cancer, to avoid overtreatment in breast and prostate cancers, or to improve follow-up and monitoring post-treatment for kidney and colorectal cancers, the goal is to provide a noninvasive companion blood test used in combination with imaging to transform clinical outcomes. We work in collaboration with Drs. Kasia Jerzak, Christopher Lim, Stanley Liu, Laurence Klotz, and Danny Vesprini.
His group also delivers “patient avatars” (patient-derived xenografts) that will help patients select the best therapy during their cancer journey. Their patient-derived xenograft platform allows them to provide pivotal information that will lead to improved response rates in advanced cancer patients. This platform can be used to evaluate chemotherapies, targeted therapies and immunotherapies. We work in collaboration with Drs. Georg Bjarnason, Robert Kerbel, Harvey Wong, and Mark Doherty.
Drug discovery is also a very important research arm, as the group implements various pre-clinical model systems to discover new drugs for various diseases (for example, kidney stones, cancer metastasis, musculoskeletal/cartilage repair).
Dr. Leong is focused on developing “liquid biopsies” that rely on the enumeration of circulating cancer cell fragments, also known as extracellular vesicles, in the blood. Whether they are used to improve early detection for early-stage migration in pancreatic cancer, to avoid overtreatment in breast and prostate cancers, or to improve follow-up and monitoring post-treatment for kidney and colorectal cancers, the goal is to provide a noninvasive companion blood test used in combination with imaging to transform clinical outcomes. We work in collaboration with Drs. Kasia Jerzak, Christopher Lim, Stanley Liu, Laurence Klotz, and Danny Vesprini.
His group also delivers “patient avatars” (patient-derived xenografts) that will help patients select the best therapy during their cancer journey. Their patient-derived xenograft platform allows them to provide pivotal information that will lead to improved response rates in advanced cancer patients. This platform can be used to evaluate chemotherapies, targeted therapies and immunotherapies. We work in collaboration with Drs. Georg Bjarnason, Robert Kerbel, Harvey Wong, and Mark Doherty.
Drug discovery is also a very important research arm, as the group implements various pre-clinical model systems to discover new drugs for various diseases (for example, kidney stones, cancer metastasis, musculoskeletal/cartilage repair).
研究兴趣
论文共 51 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Trinity Quan,Jessica Cockburn,Sukhbinder Dhesy-Thind,Anita Bane,Hon Leong, Christopher Geleff, Catherine Devion, Noor Ajel,Katarzyna J Jerzak
Gabriella C. Russo, Ashleigh J. Crawford,David Clark, Julie Cui,Ryan Carney,Michelle N. Karl,Boyang Su,Bartholomew Starich,Tung-Shing Lih, Pratik Kamat,Qiming Zhang, Praful R. Nair,
Oncogeneno. 19 (2024): 1-18
Marian Cruz-Burgos,Sergio A. Cortes-Ramirez,Alberto Losada-Garcia,Miguel Morales-Pacheco,Eduardo Martinez-Martinez,Jorge Gustavo Morales-Montor,Alejandro Servin-Haddad,J. Samuel Izquierdo-Luna,Griselda Rodriguez-Martinez,Maria del Pilar Ramos-Godinez,Vanessa Gonzalez-Covarrubias, Abraham Canavera-Constantino,
Yue Ying Yao,Dennis K Lee, Stephanie Jarvi,Marjan Farshadi, Minzhi Sheng, Sara Mar,Ori Nevo,Hon S Leong
Analytical chemistryno. 29 (2023): 10903-10912
Ahmed Makhdoum,Yasuhiro Kotani,Ryuichi Morishita,Rei Otsu, Yoshiaki Taniyama,Amine Mazine,Hon Leong,Subodh Verma,Bobby Yanagawa
Authorea (Authorea) (2022)
Prostate cancer and prostatic diseasesno. 3 (2021): 802-811
Neuro-oncologyno. 10 (2021): 1789-1797
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn